These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16892389)

  • 1. Poly(ADP-ribose)-polymerase-catalyzed hydrolysis of NAD+: QM/MM simulation of the enzyme reaction.
    Bellocchi D; Costantino G; Pellicciari R; Re N; Marrone A; Coletti C
    ChemMedChem; 2006 May; 1(5):533-9. PubMed ID: 16892389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization of mono(ADP-ribosyl)ated poly(ADP-ribose) polymerase.
    Mendoza-Alvarez H; Alvarez-Gonzalez R
    Biochemistry; 1999 Mar; 38(13):3948-53. PubMed ID: 10194306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chain length analysis of ADP-ribose polymers generated by poly(ADP-ribose) polymerase (PARP) as a function of beta-NAD+ and enzyme concentrations.
    Mendoza-Alvarez H; Chavez-Bueno S; Alvarez-Gonzalez R
    IUBMB Life; 2000 Aug; 50(2):145-9. PubMed ID: 11185961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors.
    Putt KS; Hergenrother PJ
    Anal Biochem; 2004 Mar; 326(1):78-86. PubMed ID: 14769338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of the elongation and branching reaction of poly(ADP-ribose) polymerase as derived from crystal structures and mutagenesis.
    Ruf A; Rolli V; de Murcia G; Schulz GE
    J Mol Biol; 1998 Apr; 278(1):57-65. PubMed ID: 9571033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-mitochondrial poly(ADP-ribosyl)ation: potential role for alpha-ketoglutarate dehydrogenase.
    Pankotai E; Lacza Z; Murányi M; Szabó C
    Mitochondrion; 2009 Apr; 9(2):159-64. PubMed ID: 19460292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential contribution of poly(ADP-ribose)polymerase-1 and -2 (PARP-1 and -2) to the poly(ADP-ribosyl)ation reaction in rat primary spermatocytes.
    Tramontano F; Malanga M; Quesada P
    Mol Hum Reprod; 2007 Nov; 13(11):821-8. PubMed ID: 17766683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A scintillation proximity assay for poly(ADP-ribose) polymerase.
    Cheung A; Zhang J
    Anal Biochem; 2000 Jun; 282(1):24-8. PubMed ID: 10860495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic isotope effect characterization of the transition state for oxidized nicotinamide adenine dinucleotide hydrolysis by pertussis toxin.
    Scheuring J; Schramm VL
    Biochemistry; 1997 Apr; 36(15):4526-34. PubMed ID: 9109661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology.
    Ratnam K; Low JA
    Clin Cancer Res; 2007 Mar; 13(5):1383-8. PubMed ID: 17332279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domain C of human poly(ADP-ribose) polymerase-1 is important for enzyme activity and contains a novel zinc-ribbon motif.
    Tao Z; Gao P; Hoffman DW; Liu HW
    Biochemistry; 2008 May; 47(21):5804-13. PubMed ID: 18452307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward specific functions of poly(ADP-ribose) polymerase-2.
    Yélamos J; Schreiber V; Dantzer F
    Trends Mol Med; 2008 Apr; 14(4):169-78. PubMed ID: 18353725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor and NAD+ binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling.
    Ruf A; de Murcia G; Schulz GE
    Biochemistry; 1998 Mar; 37(11):3893-900. PubMed ID: 9521710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer: an update.
    Horvath EM; Szabó C
    Drug News Perspect; 2007 Apr; 20(3):171-81. PubMed ID: 17520094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors.
    Iwashita A; Hattori K; Yamamoto H; Ishida J; Kido Y; Kamijo K; Murano K; Miyake H; Kinoshita T; Warizaya M; Ohkubo M; Matsuoka N; Mutoh S
    FEBS Lett; 2005 Feb; 579(6):1389-93. PubMed ID: 15733846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of ADP-ribosylating bacterial toxins based on oxacarbenium ion character at their transition states.
    Zhou GC; Parikh SL; Tyler PC; Evans GB; Furneaux RH; Zubkova OV; Benjes PA; Schramm VL
    J Am Chem Soc; 2004 May; 126(18):5690-8. PubMed ID: 15125661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational approaches to discovery of orally active and brain-penetrable quinazolinone inhibitors of poly(ADP-ribose)polymerase.
    Hattori K; Kido Y; Yamamoto H; Ishida J; Kamijo K; Murano K; Ohkubo M; Kinoshita T; Iwashita A; Mihara K; Yamazaki S; Matsuoka N; Teramura Y; Miyake H
    J Med Chem; 2004 Aug; 47(17):4151-4. PubMed ID: 15293985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PARP inhibitors.
    Li JH; Zhang J
    IDrugs; 2001 Jul; 4(7):804-12. PubMed ID: 15995937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered poly(ADP-ribose) metabolism impairs cellular responses to genotoxic stress in a hypomorphic mutant of poly(ADP-ribose) glycohydrolase.
    Gao H; Coyle DL; Meyer-Ficca ML; Meyer RG; Jacobson EL; Wang ZQ; Jacobson MK
    Exp Cell Res; 2007 Mar; 313(5):984-96. PubMed ID: 17276427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation.
    Kanai M; Hanashiro K; Kim SH; Hanai S; Boulares AH; Miwa M; Fukasawa K
    Nat Cell Biol; 2007 Oct; 9(10):1175-83. PubMed ID: 17891139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.